Showing session: reset
Advances in Novel Immunotherapeutics
- Sort by:
- Browse by:
- Free
- slides video
- audio + slides
- All slides included
Introduction
Kunle Odunsi
Roswell Park Cancer Inst., Buffalo, NY, United States
- Free
- slides video
- audio + slides
- All slides included
Identification of gene signatures associated with response in a Phase II trial of entinostat (ENT) plus pembrolizumab (PEMBRO) in non-small cell lung cancer (NSCLC) patients whose disease has progressed on or after anti-PD-(L)1 therapy
Suresh S Ramalingam
Winship Cancer Institute of Emory University, Atlanta, GA, United States
- Free
- audio + slides
- Some slides withheld
A phase I clinical trial of malignant pleural disease treated with regionally delivered autologous mesothelin-targeted CAR T cells: Safety and efficacy
Prasad S Adusumilli
Mem. Sloan Kettering Cancer Ctr., New York, NY, United States
- Free
- Unknown permission
for presentation
Genomic analyses and immunotherapy in advanced melanoma
F. Stephen Hodi
Dana-Farber Cancer Institute, Boston, MA, United States
- Free
- audio + slides
- Some slides withheld
Fecal microbiota transplantation (FMT) and re-induction of anti-PD-1 therapy in refractory metastatic melanoma patients - preliminary results from a phase I clinical trial (NCT03353402)
Erez N Baruch
The Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Ramat Gan, Israel
- Free
- slides video
- audio + slides
- All slides included
Results of a Phase Ib trial of an autologous cell vaccine for newly diagnosed glioblastoma
David W Andrews
Thomas Jefferson University, Philadelphia, PA, United States
- Free
- slides video
- audio + slides
- All slides included
A Phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) S1609: The neuroendocrine cohort
Sandip Pravin Patel
UCSD Moores Cancer Center, La Jolla, CA, United States
- Free
- slides video
- audio + slides
- All slides included
A Phase I trial of talimogene laherparepvec combined with neoadjuvant chemotherapy for non-metastatic triple negative breast cancer
Hatem Soliman
Moffitt Cancer Center, Tampa, FL, United States
- Free
- slides video
- audio + slides
- All slides included
Outcomes among patients (pts) with metastatic nonsquamous NSCLC with liver metastases or brain metastases treated with pembrolizumab (pembro) plus pemetrexed-platinum: Results from the KEYNOTE-189 study
Marina C Garassino
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy